Cited by 335Chronic Myeloid Leukemia TreatmentsAcute Myeloid Leukemia ResearchHematopoietic Stem Cell Transplantation

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

IL-6 Controls Leukemic Multipotent Progenitor Cell Fate and Contributes to Chronic Myelogenous Leukemia Development

Open access

Reynaud, Damien, Pietras, Eric, Barry-Holson, Keegan, Mir, Alain, Binnewies, Mikhail, Jeanne, Marion, Sala-Torra, Olga, Radich, Jerald P., Passegué, Emmanuelle·2011·Cancer Cell

DOI 10.1016/j.ccr.2011.10.012PMC PMC3220886

Open this paper in CoChat — free account Open PDF

Abstract

Using a mouse model recapitulating the main features of human chronic myelogenous leukemia (CML), we uncover the hierarchy of leukemic stem and progenitor cells contributing to disease pathogenesis. We refine the characterization of CML leukemic stem cells (LSCs) to the most immature long-term hematopoietic stem cells (LT-HSCs) and identify some important molecular deregulations underlying their aberrant behavior. We find that CML multipotent progenitors (MPPs) exhibit an aberrant B-lymphoid potential but are redirected toward the myeloid lineage by the action of the proinflammatory cytokine IL-6. We show that BCR/ABL activity controls Il-6 expression thereby establishing a paracrine feedback loop that sustains CML development. These results describe how proinflammatory tumor environment affects leukemic progenitor cell fate and contributes to CML pathogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2011.10.012

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Impaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768 · cited 2×
“IL-6 Contributes to CML Development To confirm the function of IL-6 in CML pathogenesis, we evaluated disease progression in the absence of IL-6 signaling by crossing BA mice with Il-6 / mice (Kopf et al., 1994).”
Method
An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
Iliopoulos, D., Hirsch, H. A., & Struhl, K. (2009) · Cell · doi:10.1016/j.cell.2009.10.014 · Cited by 1,374
BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Mullighan, C. G., Miller, C. B., Radtke, I., Phillips, L. A., Dalton, J., Ma, J., White, D., Hughes, T. P., Le Beau, M. M., Pui, C.-H., et al. (2008) · Nature · doi:10.1038/nature06866 · Cited by 1,072
Lin28 promotes transformation and is associated with advanced human malignancies
Viswanathan, S. R., Powers, J. T., Einhorn, W. S., Hoshida, Y., Ng, T., Toffanin, S., O’Sullivan, M. J., Lü, J., Phillips, L. A., Lockhart, V. L., et al. (2009) · Nature Genetics · doi:10.1038/ng.392 · Cited by 835
Self-citation
Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
Corbin, A. S., Agarwal, A., Loriaux, M., Cortes, J., Deininger, M. W., & Druker, B. J. (2011) · Journal of Clinical Investigation · doi:10.1172/jci35721 · Cited by 765
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors
Huntly, B. J. P., Shigematsu, H., Deguchi, K., Lee, B. H., Mizuno, S., Duclos, N., Rowan, R., Amaral, S., Curley, D., Williams, I. R., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.015 · Cited by 697
Gene expression changes associated with progression and response in chronic myeloid leukemia
Radich, J. P., Dai, H., Mao, M., Oehler, V., Schelter, J., Druker, B., Sawyers, C., Shah, N., Stock, W., Willman, C. L., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510423103 · Cited by 583
Self-citation
Isolation of a Highly Quiescent Subpopulation of Primitive Leukemic Cells in Chronic Myeloid Leukemia
Holyoake, T. L., Jiang, X., Eaves, C. J., & Eaves, A. C. (1999) · Blood · doi:10.1182/blood.v94.6.2056 · Cited by 511
Cell cycle regulation in hematopoietic stem cells
Pietras, E. M., Warr, M. R., & Passegué, E. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201102131 · Cited by 447
Self-citation
Chronic myeloid leukemia: mechanisms of blastic transformation
Perrotti, D., Jamieson, C. H. M., Goldman, J. M., & Skórski, T. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41246 · Cited by 402

Show all 34 references

Sorted by citations

Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
Functionally Distinct Subsets of Lineage-Biased Multipotent Progenitors Control Blood Production in Normal and Regenerative Conditions
Pietras, E. M., Reynaud, D., Kang, Y.-A., Carlin, D., Calero-Nieto, F. J., Leavitt, A. D., Stuart, J. M., Göttgens, B., & Passegué, E. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.05.003 · Cited by 723
Self-citation
Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche
Schepers, K., Pietras, E. M., Reynaud, D., Flach, J., Binnewies, M., Garg, T., Wagers, A. J., Hsiao, E. C., & Passegué, E. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.06.009 · Cited by 614
Self-citation
Bone marrow niches in haematological malignancies
Méndez‐Ferrer, S., Bonnet, D. A., Steensma, D. P., Hasserjian, R. P., Ghobrial, I. M., Gribben, J. G., Andreeff, M., & Krause, D. S. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0245-2 · Cited by 515
Inflammation: a key regulator of hematopoietic stem cell fate in health and disease
Pietras, E. M. (2017) · Blood · doi:10.1182/blood-2017-06-780882 · Cited by 417
Self-citation
Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities
Schepers, K., Campbell, T., & Passegue, E. A. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.02.014 · Cited by 431
Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention
Zhu, X., Chen, Z., Shen, W., Huang, G., Sedivy, J. M., Wang, H., & Ju, Z. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00646-9 · Cited by 425
Versatile functions for IL-6 in metabolism and cancer
Mauer, J., Denson, J. L., & Brüning, J. C. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.12.008 · Cited by 415
Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia
Giustacchini, A., Thongjuea, S., Barkas, N., Woll, P. S., Povinelli, B. J., Booth, C. A. G., Sopp, P., Norfo, R., Rodriguez-Meira, A., Ashley, N., et al. (2017) · Nature Medicine · doi:10.1038/nm.4336 · Cited by 403
Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis
Cai, Z., Kotzin, J. J., Ramdas, B., Chen, S., Nelanuthala, S., Palam, L. R., Pandey, R., Mali, R. S., Liu, Y., Kelley, M. R., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.10.013 · Cited by 394
TNF-α Coordinates Hematopoietic Stem Cell Survival and Myeloid Regeneration
Yamashita, M., & Passegué, E. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.05.019 · Cited by 387
Mechanisms of Relapse After CD19 CAR T-Cell Therapy for Acute Lymphoblastic Leukemia and Its Prevention and Treatment Strategies
Xu, X., Sun, Q., Liang, X., Chen, Z., Zhang, X., Zhou, X., Li, M., Tu, H., Liu, Y., Tu, S., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02664 · Cited by 360
Altered Microenvironmental Regulation of Leukemic and Normal Stem Cells in Chronic Myelogenous Leukemia
Zhang, B., Ho, Y., Huang, Q., Maeda, T., Lin, A., Lee, S.-U., Hair, A., Holyoake, T. L., Huettner, C. S., & Bhatia, R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.018 · Cited by 357
JAK–STAT Pathway Activation in Malignant and Nonmalignant Cells Contributes to MPN Pathogenesis and Therapeutic Response
Kleppe, M., Kwak, M., Koppikar, P., Riester, M., Keller, M., Bastian, L., Hricik, T., Bhagwat, N., McKenney, A. S., Papalexi, E., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0736 · Cited by 325
The chronic myeloid leukemia stem cell: stemming the tide of persistence
Holyoake, T. L., & Vetrie, D. L. P. (2017) · Blood · doi:10.1182/blood-2016-09-696013 · Cited by 319
The NF-κB Pathway and Cancer Stem Cells
Rinkenbaugh, A. L., & Baldwin, A. S. (2016) · Cells · doi:10.3390/cells5020016 · Cited by 265
Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment
Dong, L., Yu, W., Zheng, H., Loh, M. L., Bunting, S. T., Pauly, M. G., Huang, G., Zhou, M., Broxmeyer, H. E., Scadden, D. T., et al. (2016) · Nature · doi:10.1038/nature20131 · Cited by 260
Differential regulation of myeloid leukemias by the bone marrow microenvironment
Krause, D. S., Fulzele, K. S., Catic, A., Sun, C. C., Dombkowski, D., Hurley, M. P., Lezeau, S., Attar, E. C., Wu, J. Y., Lin, H. Y.-F., et al. (2013) · Nature Medicine · doi:10.1038/nm.3364 · Cited by 261
Regulation of hematopoietic and leukemic stem cells by the immune system
Riether, C., Schürch, C. M., & Ochsenbein, A. F. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.89 · Cited by 253
Ischemic Stroke Activates Hematopoietic Bone Marrow Stem Cells
Courties, G., Hérisson, F., Sager, H. B., Heidt, T., Ye, Y., Wei, Y., Sun, Y., Sévère, N., Dutta, P., Scharff, J., et al. (2014) · Circulation Research · doi:10.1161/circresaha.116.305207 · Cited by 242
Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9
Schneider, R. K., Schenone, M., Ferreira, M. S. V., Kramann, R., Joyce, C. E., Hartigan, C. R., Beier, F., Brümmendorf, T. H., Germing, U., Platzbecker, U., et al. (2016) · Nature Medicine · doi:10.1038/nm.4047 · Cited by 246
IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets
Ünver, N., & McAllister, F. M. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.04.004 · Cited by 238
An inflammatory environment containing TNFα favors Tet2-mutant clonal hematopoiesis
Abegunde, S. O., Buckstein, R., Wells, R. A., & Rauh, M. J. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2017.11.002 · Cited by 230
Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement
Bharti, R., Dey, G., & Mandal, M. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.048 · Cited by 230
Cytotoxic CD8+ T Cells Stimulate Hematopoietic Progenitors by Promoting Cytokine Release from Bone Marrow Mesenchymal Stromal Cells
Schürch, C. M., Riether, C., & Ochsenbein, A. F. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.01.002 · Cited by 223
Pro-inflammatory cytokines: Emerging players regulating HSC function in normal and diseased hematopoiesis
Mirantes, C., Passegué, E., & Pietras, E. M. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.08.017 · Cited by 211
Self-citation
Myeloid progenitor cluster formation drives emergency and leukaemic myelopoiesis
Hérault, A., Binnewies, M., Leong, S., Calero‐Nieto, F. J., Zhang, S. Y., Kang, Y.-A., Wang, X., Pietras, E. M., Chu, S. H., Barry-Holson, K. Q., et al. (2017) · Nature · doi:10.1038/nature21693 · Cited by 215
Self-citation
Depletion of Jak2V617F myeloproliferative neoplasm-propagating stem cells by interferon-α in a murine model of polycythemia vera
Mullally, A., Bruedigam, C., Poveromo, L., Heidel, F. H., Purdon, A. S., Vu, T., Austin, R. J., Heckl, D., Breyfogle, L. J., Kuhn, C. P., et al. (2013) · Blood · doi:10.1182/blood-2012-05-432989 · Cited by 200
Long-term cultured mesenchymal stem cells frequently develop genomic mutations but do not undergo malignant transformation
Wang, Y., Zhang, Z., Chi, Y., Zhang, Q., Xu, F., Yang, Z., Meng, L., Yang, S., Yan, S., Mao, A., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.480 · Cited by 185
Chronic Myeloid Leukemia: A Model Disease of the Past, Present and Future
Minciacchi, V. R., Kumar, R., & Krause, D. S. (2021) · Cells · doi:10.3390/cells10010117 · Cited by 195
Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells
Agarwal, P., Isringhausen, S., Li, H., Paterson, A. J., He, J., Gomariz, Á., Nagasawa, T., Nombela‐Arrieta, C., & Bhatia, R. (2019) · Cell stem cell · doi:10.1016/j.stem.2019.02.018 · Cited by 184
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
Koschmieder, S., Mughal, T. I., Hasselbalch, H. C., Barosi, G., Valent, P., Kiladjian, J., Jeryczynski, G., Gisslinger, H., Jutzi, J. S., Pahl, H. L., et al. (2016) · Leukemia · doi:10.1038/leu.2016.12 · Cited by 179
Hematopoietic Stem Cell and Its Bone Marrow Niche
Yu, V. W. C., & Scadden, D. T. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.01.009 · Cited by 179
Clonal haematopoiesis and dysregulation of the immune system
Belizaire, R., Wong, W. J., Robinette, M. L., & Ebert, B. L. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00843-3 · Cited by 161
Senescence-associated secretory phenotype favors the emergence of cancer stem-like cells
Cahu, J., Bustany, S., & Sola, B. (2012) · Cell Death & Disease · doi:10.1038/cddis.2012.183 · Cited by 160
Microenvironmental contributions to hematopoietic stem cell aging
Ho, Y., & Méndez‐Ferrer, S. (2019) · Haematologica · doi:10.3324/haematol.2018.211334 · Cited by 156
Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors
Henry, C. J., Casás-Selves, M., Kim, J., Zaberezhnyy, V., Aghili, L., Daniel, A. E., Jimenez, L., Azam, T., McNamee, E. N., Clambey, E. T., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci83024 · Cited by 148
Molecular Mechanisms of Cancer-Induced Sleep Disruption
Walker, W. H., II, & Borniger, J. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112780 · Cited by 149
MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice
Zhao, J. L., Rao, D. S., O’Connell, R. M., Garcia-Flores, Y., & Baltimore, D. (2013) · eLife · doi:10.7554/elife.00537 · Cited by 140
Regulation of c-Myc Ubiquitination Controls Chronic Myelogenous Leukemia Initiation and Progression
Reavie, L. B., Buckley, S. M., Loizou, E., Takeishi, S., Aranda-Orgillés, B., Ndiaye‐Lobry, D., Abdel-Wahab, O. I., Ibrahim, S., Nakayama, K. I., & Aifantis, I. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.025 · Cited by 133
Treatment of Chronic Myelogenous Leukemia by Blocking Cytokine Alterations Found in Normal Stem and Progenitor Cells
Welner, R. S., Amabile, G., Bararia, D., Czibere, A. G., Yang, H. H., Zhang, H., de Figueiredo‐Pontes, L. L., Ye, M., Levantini, E., Ruscio, A. D., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.004 · Cited by 135
Clonal hematopoiesis and inflammation: Partners in leukemogenesis and comorbidity
Cook, E. K., Luo, M., & Rauh, M. J. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.01.011 · Cited by 124
Coordinate regulation of residual bone marrow function by paracrine trafficking of AML exosomes
Huan, J., Hornick, N. I., Goloviznina, N. A., Kamimae-Lanning, A. N., David, L. L., Wilmarth, P. A., Mori, T., Chevillet, J. R., Narla, A., Roberts, C. T., et al. (2015) · Leukemia · doi:10.1038/leu.2015.163 · Cited by 126
Neural regulation of bone and bone marrow
Maryanovich, M., Takeishi, S., & Frenette, P. S. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031344 · Cited by 114
Eosinophils regulate adipose tissue inflammation and sustain physical and immunological fitness in old age
Brigger, D., Riether, C., van Brummelen, R., Mosher, K. I., Shiu, A., Ding, Z., Bachmeier‐Zbären, N., Gasser, P., Guntern, P., Yousef, H., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0228-3 · Cited by 119
How I treat chronic myelomonocytic leukemia
Solary, É., & Itzykson, R. (2017) · Blood · doi:10.1182/blood-2017-04-736421 · Cited by 112
Inflammatory signaling regulates hematopoietic stem and progenitor cell development and homeostasis
Collins, A., Mitchell, C. A., & Passegué, E. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201545 · Cited by 111
Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agent
Xiang, M. H., Kim, H. T., Ho, V. T., Walker, S. R., Bar‐Natan, M., Anahtar, M., Liu, S., Toniolo, P. A., Kroll, Y., Jones, N., et al. (2016) · Blood · doi:10.1182/blood-2015-07-660506 · Cited by 110
The hematopoietic stem-cell niche in health and leukemia
Sánchez‐Aguilera, A., & Méndez‐Ferrer, S. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2306-y · Cited by 119
An evolutionary perspective on chronic myelomonocytic leukemia
Itzykson, R., & Solary, É. (2013) · Leukemia · doi:10.1038/leu.2013.100 · Cited by 108
Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells
Hemmati, S., Haque, T. Z., & Gritsman, K. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00265 · Cited by 104
Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases
Chiba, Y., Mizoguchi, I., Hasegawa, H., Ohashi, M., Orii, N., Nagai, T., Sugahara, M., Miyamoto, Y., Xu, M., Owaki, T., et al. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2724-5 · Cited by 105
Made to order: emergency myelopoiesis and demand-adapted innate immune cell production
Swann, J. W., Olson, O. C., & Passegue, E. A. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-00998-7 · Cited by 108
The IL-6 feed-forward loop: A driver of tumorigenesis
Chang, Q., Daly, L., & Bromberg, J. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.007 · Cited by 99
Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia
Kesarwani, M., Kincaid, Z., Gomaa, A. R., Huber, E., Rohrabaugh, S., Siddiqui, Z., Bouso, M. F., Latif, T., Xu, M., Komurov, K., et al. (2017) · Nature Medicine · doi:10.1038/nm.4310 · Cited by 98
Overview of the STAT‑3 signaling pathway in cancer and the development of specific inhibitors (Review)
Gu, Y., Mohammad, I., & Liu, Z. (2020) · Oncology Letters · doi:10.3892/ol.2020.11394 · Cited by 103
JAK2V617F homozygosity drives a phenotypic switch in myeloproliferative neoplasms, but is insufficient to sustain disease
Li, J., Kent, D. G., Godfrey, A. L., Manning, H., Nangalia, J., Aziz, A., Chen, E., Saeb‐Parsy, K., Fink, J., Sneade, R., et al. (2014) · Blood · doi:10.1182/blood-2013-06-510222 · Cited by 94
Mitochondrial Transfer in the Leukemia Microenvironment
Griessinger, E., Moschoi, R., Biondani, G., & Peyron, J. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.10.003 · Cited by 99
Chronic myelogenous leukemia cells remodel the bone marrow niche via exosome-mediated transfer of miR-320
Gao, X., Wan, Z., Wei, M., Dong, Y., Zhao, Y., Chen, X., Li, Z., Qin, W., Yang, G., & Liu, L. (2019) · Theranostics · doi:10.7150/thno.34813 · Cited by 94
IL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms
Mager, L. F., Riether, C., Schürch, C. M., Banz, Y., Wasmer, M.-H., Stuber, R., Theocharides, A. P. A., Li, X., Xia, Y., Saito, H., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77347 · Cited by 95
FoxO1-dependent induction of acute myeloid leukemia by osteoblasts in mice
Kode, A., Mosialou, I., Manavalan, S. J., Rathinam, C., Friedman, R. A., Teruya‐Feldstein, J., Bhagat, G., Berman, E., & Kousteni, S. (2015) · Leukemia · doi:10.1038/leu.2015.161 · Cited by 91
The hematopoietic stem cell niche—home for friend and foe?
Krause, D. S., Scadden, D. T., & Preffer, F. I. (2012) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.21066 · Cited by 96
The cytokine network in acute myeloid leukemia
Luciano, M., Krenn, P. W., & Horejs‐Hoeck, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1000996 · Cited by 91
Regulation of stress-induced hematopoiesis
Zhao, J. L., & Baltimore, D. (2015) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000149 · Cited by 97
Biological effects of interleukin-6: Clinical applications in autoimmune diseases and cancers
Ho, L., Luo, S., & Lai, J. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.009 · Cited by 89
The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment
Aguilar‐Cázares, D., Chavez-Dominguez, R., Marroquin-Muciño, M., Perez-Medina, M., Benito-Lopez, J. J., Camarena, Á., Rumbo‐Nava, U., & López-González, J. S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.929572 · Cited by 85
Distinct roles for long-term hematopoietic stem cells and erythroid precursor cells in a murine model of Jak2V617F-mediated polycythemia vera.
Mullally, A., Poveromo, L., Schneider, R., Al-Shahrour, F., Lane, S., & Ebert, B. (2012) · Blood · doi:10.1182/blood-2012-01-402396 · Cited by 80
Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age?
DeGregori, J. V. (2012) · Oncogene · doi:10.1038/onc.2012.281 · Cited by 88
Inflammatory bone marrow microenvironment
Leimkühler, N. B., & Schneider, R. K. (2019) · Hematology · doi:10.1182/hematology.2019000045 · Cited by 82
Clinical and histopathologic review of Schnitzler syndrome: The Mayo Clinic experience (1972-2011)
Sokumbi, O., Drage, L. A., & Peters, M. S. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.04.027 · Cited by 81
The bone marrow niche, stem cells, and leukemia: impact of drugs, chemicals, and the environment
Greim, H. A., Kaden, D. A., Larson, R. A., Palermo, C. M., Rice, J. M., Ross, D., & Snyder, R. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12362 · Cited by 83
Obesity alters the long-term fitness of the hematopoietic stem cell compartment through modulation of Gfi1 expression
Lee, J.-M., Govindarajah, V., Goddard, B., Hinge, A. S., Muench, D. E., Filippi, M., Aronow, B. J., Cancelas, J. A., Salomonis, N., Grimes, H. L., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20170690 · Cited by 83
Self-citation
Turning the tide in myelodysplastic/myeloproliferative neoplasms
Deininger, M. W., Tyner, J. W., & Solary, É. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.40 · Cited by 88
Normal Hematopoiesis Is a Balancing Act of Self-Renewal and RegenerationPreprint
Olson, O. C., Kang, Y.-A., & Passegue, E. A. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a035519 · Cited by 89
IL-6 blockade reverses bone marrow failure induced by human acute myeloid leukemia
Zhang, T. Y., Dutta, R., Benard, B. A., Zhao, F., Yin, R. R., & Majeti, R. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax5104 · Cited by 77
The Multiple Layers of the Tumor Environment
Laplane, L., Duluc, D., Larmonier, N., Pradeu, T., & Bikfalvi, A. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.10.002 · Cited by 74
Dissecting the role of aberrant DNA methylation in human leukaemia
Amabile, G., Ruscio, A. D., Müller, F., Welner, R. S., Yang, H. H., Ebralidze, A. K., Zhang, H., Levantini, E., Qi, L., Martinelli, G., et al. (2015) · Nature Communications · doi:10.1038/ncomms8091 · Cited by 72
Myelodysplastic syndrome-associated spliceosome gene mutations enhance innate immune signaling
Pollyea, D. A., Harris, C., Rabe, J. L., Hedin, B. R., Arras, L. D., Katz, S., Wheeler, E. C., Bejar, R. L., Walter, M. J., Jordan, C. T., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.214155 · Cited by 72
Self-citation
Obesity-induced inflammation: The impact of the hematopoietic stem cell niche
Bowers, E., & Singer, K. (2021) · JCI Insight · doi:10.1172/jci.insight.145295 · Cited by 72
The IL-2/CD25 axis maintains distinct subsets of chronic myeloid leukemia-initiating cells
Kobayashi, C. I., Takubo, K., Kobayashi, H., Nakamura‐Ishizu, A., Honda, H., Kataoka, K., Kumano, K., Akiyama, H., Sudo, T., Kurokawa, M., et al. (2014) · Blood · doi:10.1182/blood-2013-07-517847 · Cited by 68
CDK6 Inhibition: A Novel Approach in AML Management
Uras, I. Z., Sexl, V., & Kollmann, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072528 · Cited by 65
Dipeptide species regulate p38MAPK–Smad3 signalling to maintain chronic myelogenous leukaemia stem cells
Naka, K., Jomen, Y., Ishihara, K., Kim, J., Ishimoto, T., Bae, E., Mohney, R. P., Stirdivant, S. M., Oshima, H., Oshima, M., et al. (2015) · Nature Communications · doi:10.1038/ncomms9039 · Cited by 64
A competitive electrochemical immunosensor for the detection of human interleukin-6 based on the electrically heated carbon electrode and silver nanoparticles functionalized labels
Lou, Y., He, T., Jiang, F., Shi, J., & Zhu, J. (2014) · Talanta · doi:10.1016/j.talanta.2014.01.016 · Cited by 63
Neutrophil Homeostasis and Emergency Granulopoiesis: The Example of Systemic Juvenile Idiopathic Arthritis
Malengier‐Devlies, B., Metzemaekers, M., Wouters, C. H., Proost, P., & Matthys, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.766620 · Cited by 64
NrasG12D/+ promotes leukemogenesis by aberrantly regulating hematopoietic stem cell functions
Wang, J., Kong, G., Liu, Y., Du, J., Chang, Y., Tey, S.-R., Zhang, X., Ranheim, E. A., Saba-El-Leil, M. K., Meloche, S., et al. (2013) · Blood · doi:10.1182/blood-2012-12-475863 · Cited by 63
Selective elimination of leukemia stem cells: Hitting a moving target
Crews, L. A., & Jamieson, C. H. M. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.08.006 · Cited by 63
Cytokine Regulation of Microenvironmental Cells in Myeloproliferative Neoplasms
Hoermann, G., Greiner, G., & Valent, P. (2015) · Mediators of Inflammation · doi:10.1155/2015/869242 · Cited by 61
p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion
Hong, B., Li, H., Zhang, M., Xu, J., Lu, Y., Zheng, Y., Qian, J., Chang, J. T., Yang, J., & Yi, Q. (2014) · International Journal of Cancer · doi:10.1002/ijc.28958 · Cited by 59
Inflammatory Cytokines Shape an Altered Immune Response During Myeloid Malignancies
Camacho, V., Kuznetsova, V., & Welner, R. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.772408 · Cited by 60
Role of STAT3 in Transformation and Drug Resistance in CML
Nair, R. R., Tolentino, J. H. G., & Hazlehurst, L. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00030 · Cited by 57
Bone marrow inflammation in haematological malignancies
de Jong, M. M. E., Chen, L., Raaijmakers, M. H. G. P., & Cupedo, T. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01003-x · Cited by 54
Macrophages Derived From Human Induced Pluripotent Stem Cells: The Diversity of Protocols, Future Prospects, and Outstanding Questions
Lyadova, I. V., Gerasimova, T., & Nenasheva, T. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.640703 · Cited by 56
Molecular biology of chronic myeloid leukemia
Maru, Y. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02346.x · Cited by 54
Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasm
Kong, G., Wunderlich, M., Yang, D. T., Ranheim, E. A., Young, K. H., Wang, J., Chang, Y., Du, J., Liu, Y., Tey, S.-R., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74182 · Cited by 52
Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations
Traer, E. A., Javidi‐Sharifi, N., Agarwal, A., Dunlap, J. B., English, I. A., Martinez, J., Tyner, J. W., Wong, M., & Druker, B. J. (2014) · Blood · doi:10.1182/blood-2013-07-518381 · Cited by 52
Stem cell persistence in CML is mediated by extrinsically activated JAK1-STAT3 signaling
Kuepper, M. K., Bütow, M., Herrmann, O., Ziemons, J., Chatain, N., Maurer, A., Kirschner, M., Maié, T., Costa, I. G., Eschweiler, J., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0427-7 · Cited by 53
TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy
Nievergall, E., Reynolds, J., Kok, C. H., Watkins, D. B., Biondo, M., Busfield, S. J., Vairo, G., Fuller, K. A., Erber, W. N., Sadras, T., et al. (2016) · Leukemia · doi:10.1038/leu.2016.34 · Cited by 51
Aberrant Notch Signaling in the Bone Marrow Microenvironment of Acute Lymphoid Leukemia Suppresses Osteoblast-Mediated Support of Hematopoietic Niche Function
Wang, W., Zimmerman, G., Huang, X., Yu, S., Myers, J., Wang, Y., Moreton, S. A., Nthale, J. M., Awadallah, A., Beck, R. C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2092 · Cited by 50
Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6-dependent manner
Peña‐Martínez, P., Eriksson, M. D., Ramakrishnan, R., Chapellier, M., Högberg, C., Orsmark‐Pietras, C., Richter, J., Andersson, A., Fioretos, T., & Järås, M. (2017) · Leukemia · doi:10.1038/leu.2017.261 · Cited by 49
PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL + human leukemia
Lai, D., Chen, M., Su, J., Liu, X., Rothe, K., Hu, K., Forrest, D. L., Eaves, C. J., Morin, G. B., & Jiang, X. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan8735 · Cited by 47

Authors: Reynaud, D., Pietras, E., Barry-Holson, K., Mir, A., Binnewies, M., Jeanne, M., Sala-Torra, O., Radich, J. P., & Passegué, E.
Affiliations: University of California, San Francisco (US)
Standard BioTools (United States) (US)
Fred Hutch Cancer Center (US)
Corresponding author: Reynaud, Damien
ORCID: Reynaud, Damien
Pietras, Eric
Binnewies, Mikhail
Jeanne, Marion
Radich, Jerald P.
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2011-11
Volume: 20
Issue: 5
Pages: 661-673
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/j.ccr.2011.10.012
PMC: PMC3220886
OpenAlex: W1974815398
Cited by: 335
References: 34
Citations by year: 2026: 10 · 2025: 22 · 2024: 17 · 2023: 26 · 2022: 26 · 2021: 33 · 2020: 27 · 2019: 23 · 2018: 19 · 2017: 25 · 2016: 20 · 2015: 28 · 2014: 24 · 2013: 19 · 2012: 16
FWCI: 12.92
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 624 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
University of California, San Francisco
National Heart, Lung, and Blood Institute (HL092471, R01HL092471)
Topics: Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Keywords: interleukin-6, chronic myeloid leukemia, multipotent progenitors, leukemia stem cells, long-term hematopoietic stem cells, BCR-ABL, myeloid differentiation, paracrine signaling, cell fate specification
MeSH terms: Animals, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Interleukin-6, Fusion Proteins, bcr-abl, Feedback, Physiological, Multipotent Stem Cells, Mice, Precursor Cells, B-Lymphoid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

IL-6 Controls Leukemic Multipotent Progenitor Cell Fate and Contributes to Chronic Myelogenous Leukemia Development

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks